The Memo: Nia Therapeutics Unlocking the Brain’s Potential to Restore Memory
Under the direction of Co-Founders Dan Rizzuto, President & Chief Technical Officer, and Mike Kahana, Chief Executive Officer, Nia Therapeutics is developing cutting-edge neurostimulation technology to restore memory function. The company’s innovation targets memory loss resulting from TBI, neurodegenerative diseases, and other conditions, aiming to improve patients’ quality of life and redefine the treatment landscape. This blog is originally published here: https://www.lifesciencemarketr....esearch.com/insights